Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > What makes more sense with this, setting up for
View:
Post by Dcutter101 on Feb 15, 2022 10:01am

What makes more sense with this, setting up for

expanding existing product sales or are we setting up for a takeover by Pfizer or someone.... this is a headline for after a new approval or something else to sell....
Comment by mikeq113 on Feb 15, 2022 11:00am
Or is it possible this will precede another PR prior to the quarterly earnings call? It would make a lot more sense if this is done in anticipation of a rapidly advancing cancer pipeline and/or late stage NASH trial.  wishful thinking for now I suppose. 
Comment by Dcutter101 on Feb 15, 2022 11:05am
But neither of those are close to needing a sales team...
Comment by SPCEO1 on Feb 15, 2022 12:03pm
This is all part of Paul building a bigger company. NASH sales are defintely no where on the horizon a s the pahse III test will take a long time to complete. Cancer, if all goes well in the trials, may be an approved and marketable product much much faster as it may not need more than one phase 2 to get accelerated approval. So, they could be planning for that and this would be the most ...more  
Comment by palinc2000 on Feb 15, 2022 12:57pm
I dont see the need for reading tea leaves into this PR Straight and simple......rebuilding the sales function for existing products and maybe for a projected product acquisition ,,,,,nothing related to phase 1 a cancer results
Comment by qwerty22 on Feb 15, 2022 3:06pm
I do think we are in the middle of something like a 5 year project to transform this company under Paul's vision. I'd assume this is part of that. I think you are probably right though about this being about existing products. I believe he wants to bring his experience of selling rare disease drug with Pfizer to these products and that maybe what he envisioned couldn't be done with a ...more  
Comment by palinc2000 on Feb 15, 2022 4:22pm
Paul was dealt a hand consisting of very little sales barely cashf flow positive ,cash that was and is still all owed to Convert holders ,an unproven oncology platform which was bought for allmost zero and requires cash outlays to finance clinical trials and a Nash HIV trial which never received approval by FDa and  was later approved by FDA for general Nash ..and for which funds are not yet ...more  
Comment by palinc2000 on Feb 15, 2022 4:46pm
I once posted that my investment thesis in THTX was based on my confidence in Paul.....I admit that I have sometimes suffered from a lower confidence level  but today s PR gives me a higher confidence level.......
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities